The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women
Authors:
- 14 December 2023
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 104 (3) , 100303
Abstract
No abstract availableKeywords
Funding Information
- Agency for Science, Technology and Research (C211318003)
- National Medical Research Council (OFYIRG19may-0007)
- National Medical Research Council (MOH-000323-00)
This publication has 61 references indexed in Scilit:
- High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasisOncoTargets and Therapy, 2014
- IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patientsJournal of Clinical Investigation, 2013
- Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burdenOncoImmunology, 2013
- A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human diseaseBMC Cancer, 2012
- Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast CancerJournal of Clinical Oncology, 2011
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in MiceGastroenterology, 2010
- Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigensProceedings of the National Academy of Sciences, 2010
- Autocrine regulation of T‐cell activation by ATP release and P2X 7 receptorsThe FASEB Journal, 2009
- Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancerEuropean Journal of Cancer, 2008
- Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell levelEuropean Journal of Immunology, 2005